Pharmaceutical

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products Retail The Market Buzz Your Environment

Eli Lilly Seeks to Cut Insulin Costs as Walmart Debuts Lower-Price Rival

Rebecca Urena06/29/2021

2671

Walmart introduced a less expensive version of analog insulin and Eli Lilly (NYSE: LLY) CEO David Ricks revealed it is ready for the competition. Walmart announced Tuesday that it...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA adds Heart Inflammation Warning on Pfizer & Moderna Covid Vaccines

Rebecca Urena06/28/202106/28/2021

3802

On Friday, the U.S. Food and Drug Administration added a warning to Moderna and Pfizer-BioNTech Covid-19 vaccines regarding a rare risk of heart inflammation. Pfizer and Moderna’s fact sheets...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz

AstraZeneca, EU Both Claim to Win Court Case Regarding Vaccine Delivery

Rebecca Urena06/18/2021

3741

AstraZeneca (OTCMKTS: AZNCF) and the European Union (EU) both claim to have won a legal battle in which the EU accused the pharmaceutical company of not producing enough vaccine...

Biotechnology Healthcare Market News Pharmaceutical Science Technology The Market Buzz

Citius Pharmaceuticals, Inc. Expands Scientific Advisory Board

Nikita Medvedev06/15/2021

1434

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) finds itself up over 15% going into Tuesday’s market close after the Company announced that Dr. John Laffey, a leading scholar in Acute Respiratory...

Breaking News Market News Pharmaceutical Science Technology The Buzz The Buzz TV The Market Buzz Video

“The Buzz” Show: Clearside Biomedical, Inc. (NASDAQ: CLSD) Reports Positive Safety Results

financial buzz06/15/202106/16/2021

1611

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Clearside Biomedical, Inc. (NASDAQ: CLSD) Reports Positive Safety Results” Clearside Biomedical, Inc. (NASDAQ: CLSD) a biopharmaceutical company dedicated...

Market News Pharmaceutical Science Technology The Market Buzz

Clearside Biomedical Reports Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial

Bryan Shin06/15/202106/15/2021

3889

Clearside Biomedical, Inc. (NASDAQ: CLSD) a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, reported...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Moderna Requests FDA Approval to Vaccinate Kids 12 to 17

Rebecca Urena06/10/202106/10/2021

3219

Moderna (NASDAQ: MRNA), an American pharmaceutical and biotechnology company, has requested that the Food and Drug Administration grant it emergency use of its Covid-19 vaccine in kids ages 12...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

J&J CEO Reveals that Annual Covid Vaccines May be Necessary

Rebecca Urena06/09/202106/09/2021

2309

Johnson & Johnson (NYSE: JNJ) CEO Alex Gorsky said Wednesday that people will probably need to receive various Covid-19 vaccine doses in addition to their annual flu shot for...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products Technology The Market Buzz Your Environment

Biogen Receives FDA Approval for Alzheimer’s Drug

Rebecca Urena06/07/202106/07/2021

2625

On Monday, The Food and Drug Administration, approved Biogen’s (NASDAQ: BIIB) Alzheimer’s disease drug aducanumab. The medication, which delays the cognitive decline in patients with Alzheimer’s, is the first...

Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Johnson & Johnson’s Appeal Rejected by Supreme Court

Rebecca Urena06/01/202106/01/2021

2446

The Supreme Court denied Johnson & Johnson’s (NYSE: JNJ) appeal to undo a USD2.1 Billion award regarding allegations that its talc powder products contained asbestos, which caused ovarian cancer...

Eli Lilly Seeks to Cut Insulin Costs as Walmart Debuts Lower-Price Rival

FDA adds Heart Inflammation Warning on Pfizer & Moderna Covid Vaccines

AstraZeneca, EU Both Claim to Win Court Case Regarding Vaccine Delivery

Citius Pharmaceuticals, Inc. Expands Scientific Advisory Board

“The Buzz” Show: Clearside Biomedical, Inc. (NASDAQ: CLSD) Reports Positive Safety Results

Clearside Biomedical Reports Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial

Moderna Requests FDA Approval to Vaccinate Kids 12 to 17

J&J CEO Reveals that Annual Covid Vaccines May be Necessary

Biogen Receives FDA Approval for Alzheimer’s Drug

Johnson & Johnson’s Appeal Rejected by Supreme Court

ABOUT US

Tweets